Literature DB >> 12834859

Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.

Jung Chung Lin1.   

Abstract

We report here that glycyrrhizic acid (GL), a component of licorice root (Glycyrrhiza radix), is active against EBV replication in superinfected Raji cells in a dose-dependent fashion. The IC(50) values for viral inhibition and cell growth were 0.04 and 4.8mM, respectively. The selectivity index (ratio of IC(50) for cell growth to IC(50) for viral DNA synthesis) was 120. Time of addition experiments suggested that GL interferes with an early step of EBV replication cycle (possibly penetration). GL had no effect on viral adsorption, nor did it inactivate EBV particles. Thus, GL represents a new class of anti-EBV compounds with a mode of action different from that of the nucleoside analogs that inhibit viral DNA polymerase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834859     DOI: 10.1016/s0166-3542(03)00030-5

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  38 in total

1.  Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.

Authors:  Hyojeung Kang; Paul M Lieberman
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 2.  Bioactive activities of natural products against herpesvirus infection.

Authors:  Myoungki Son; Minjung Lee; Gi-Ho Sung; Taeho Lee; Yu Su Shin; Hyosun Cho; Paul M Lieberman; Hyojeung Kang
Journal:  J Microbiol       Date:  2013-10-31       Impact factor: 3.422

3.  The renoprotective effect of glycyrrhizic acid in insulin-resistant rats exposed to aluminum involves the inhibition of TLR4/NF-κB signaling pathway.

Authors:  Noha A Emara; Mona F Mahmoud; Hassan M El Fayoumi; Amr A A Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-09       Impact factor: 3.000

Review 4.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.

Authors:  Francesca Curreli; Alvin E Friedman-Kien; Ornella Flore
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.

Authors:  Yih-Yih Kok; Wan-Loy Chu; Siew-Moi Phang; Shar Mariam Mohamed; Rakesh Naidu; Pey-Jiun Lai; Shui-Nyuk Ling; Joon-Wah Mak; Patricia Kim-Chooi Lim; Pauline Balraj; Alan Soo-Beng Khoo
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

7.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

8.  Synthesis and antiviral activities of spacer-linked 1-thioglucuronide analogues of glycyrrhizin.

Authors:  Christian Stanetty; Andrea Wolkerstorfer; Hassan Amer; Andreas Hofinger; Ulrich Jordis; Dirk Claßen-Houben; Paul Kosma
Journal:  Beilstein J Org Chem       Date:  2012-05-08       Impact factor: 2.883

Review 9.  Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.

Authors:  Changchao Huan; Yao Xu; Wei Zhang; Tingting Guo; Haochun Pan; Song Gao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

10.  Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.

Authors:  Yoshihiro Matsumoto; Tomokazu Matsuura; Haruyo Aoyagi; Mami Matsuda; Su Su Hmwe; Tomoko Date; Noriyuki Watanabe; Koichi Watashi; Ryosuke Suzuki; Shizuko Ichinose; Kenjiro Wake; Tetsuro Suzuki; Tatsuo Miyamura; Takaji Wakita; Hideki Aizaki
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.